Friday, October 2, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 21, 2026

3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes

View original at finance.yahoo.com
3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes The Medical Info Systems industry continues to expand rapidly, driven by innovations in healthcare resource management, patient data handling and integrated digital care delivery…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 79% of health systems reported increasing their investments in digital health solutions over the past two years

    80% confidence
  • Medical Info Systems industry carries Zacks Industry Rank #161, placing it in bottom 34% of 244 Zacks industries, indicating dull near-term prospects

    80% confidence
  • Top 50% of Zacks-ranked industries outperform bottom 50% by a factor of more than 2 to 1

    80% confidence
  • Global Smart Healthcare Products market was valued at $280.48 billion in 2024 and is expected to reach $796.36 billion by 2032, at a CAGR of 15.37%

    80% confidence
  • Doximity has 95% subscription-based revenue model with strong net revenue retention

    80% confidence
  • Doximity is expanding across a $18.55 billion total addressable market

    80% confidence
  • The use of AI in healthcare market is expected to witness a CAGR of 38.6% during 2025-2030, propelled by growing demand for enhanced diagnostic accuracy, optimized workflows and personalized medicine

    80% confidence
  • Omnicell's revenues expected to witness 2.8% CAGR during 2025-2027

    80% confidence
  • In 2025, ransomware and cyberattacks rose sharply, increasingly targeting healthcare organizations and service partners, disrupting operations and exposing patient data

    80% confidence
  • Doximity covers over 80% of U.S. doctors and 60% of advanced practitioners

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com